FDA QMSR: What Changed and Why It Matters

Date: February 2, 2026
Category: US Regulations
Description: FDA’s Quality Management System Regulation (QMSR) revises 21 CFR Part 820 by making ISO 13485:2016 the core set of quality management system requirements for most medical device manufacturers. Compared with the legacy Quality System Regulation (QSR), which spelled out requirements directly in Part 820 Subparts A through O, the QMSR approach relies on incorporation by reference to ISO 13485, with a small set of FDA provisions retained or added to avoid gaps or conflicts with other U.S. requirements. The final rule was published February 2, 2024 and is effective February 2, 2026.
Key changes from QSR to QMSR
ISO 13485:2016 is now the primary quality management system requirement within Part 820, and FDA incorporates Clause 3 of ISO 9000:2015 for aligned terminology.
Part 820 is restructured to function as an overlay on ISO 13485. FDA keeps or adds specific provisions where U.S. regulatory obligations drive additional clarity.
Records and traceability expectations are explicitly linked to U.S. requirements in areas manufacturers routinely need during postmarket investigations, including complaint evaluation, servicing records, and documentation that supports medical device reporting and UDI requirements where applicable.
Labeling and packaging controls are explicitly carried forward in Part 820, rather than relying only on ISO 13485 text.
FDA states it will have the authority to inspect management review, internal quality audit, and supplier audit reports. The legacy exception in 21 CFR 820.180(c) is not maintained.
FDA indicates it will transition to an updated device inspection compliance program aligned to QMSR on the effective date.
What this means for business operations
If you already run an ISO 13485 QMS, the work is mainly in confirming coverage of FDA’s Part 820 additions and strengthening the link between ISO processes and U.S.-specific postmarket requirements. Focus on records organization and retrieval, not just procedure wording.
If your system is built around legacy Part 820, expect a clause-mapping and training effort. Procedures, templates, and audit checklists need to align to the ISO structure while maintaining U.S. regulatory traceability for inspections.
Inspection readiness changes. Internal audit, supplier audit, and management review outputs should be treated as potentially reviewable evidence. This affects how issues are documented, trended, and closed, and how management review inputs and outputs are controlled.
Supplier oversight may need updates, including audit planning, documentation practices, and quality agreements that assume audit reports may be requested by the FDA.
Practical actions to take now
Build a QSR-to-ISO 13485 crosswalk and perform a gap assessment against ISO clauses plus the FDA Part 820 overlay.
Update record control and retrieval for complaints and servicing, and confirm data elements needed for MDR decision-making and reporting timelines.
Confirm where UDI must be captured in records and ensure the data flow from labeling to production and postmarket processes is controlled and auditable.
Reconfirm labeling and packaging controls against the revised Part 820 expectations and existing 21 CFR Part 801 obligations.
Update audit and management review practices and train teams with the expectation FDA may request the reports during inspection.
Sources (for reference)
FDA. Quality Management System Regulation (QMSR) Overview. https://www.fda.gov/medical-devices/postmarket-requirements-devices/quality-management-system-regulation-qmsr
FDA. Quality Management System Regulation Final Rule Frequently Asked Questions. https://www.fda.gov/medical-devices/quality-system-qs-regulationmedical-device-current-good-manufacturing-practices-cgmp/quality-management-system-regulation-final-rule-amending-quality-system-regulation-frequently-asked
Federal Register. Medical Devices; Quality System Regulation Amendments (Final Rule). February 2, 2024. https://www.govinfo.gov/content/pkg/FR-2024-02-02/pdf/2024-01709.pdf
21 CFR Part 820 (pre-QMSR), including §820.180(c). https://www.ecfr.gov/current/title-21/chapter-I/subchapter-H/part-820